We conclude that long-term activation of mTORC1 by LTsc1KO, upstream regulators (Dddit4) of mTORC1 was impaired; meanwhile, expression of downstream genes (Nupr1 and FGF21) of mTORC1 was decreased, resulting in metabolic disorder and mitochondrial defects. This evidence concerns the gene NUPR1 and metabolic disease.